Internal Medicine, Allergy & Immunology · Williamsville, NY
NPI
1922368737
Since 2012
Specialty
Internal Medicine, Allergy & Immunology
Code 207RA0201X
Group practices
2
Medicare group memberships
Hospitals
0
Hospital affiliations
1020 Youngs Rd
Williamsville, NY, 14221
Phone (716) 961-9900
Groups this clinician bills Medicare through
Medicare paid, 2024
$5,939
215 services
Medicare patients, 2024
47
Average age 69
Drug cost, 2024
$1.3M
921 prescriptions
Company payments, 2025
$935
From 6 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Aasha Harish was code 99214 (office e&m - established), 31 times for 18 patients. In total Aasha Harish billed 215 services in 10 codes, and Medicare paid $5,939.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2018-12-14.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99214 Office E&M - Established | Office | 31 | 18 | $88.68 | $2,749 |
| 99213 Office E&M - Established | Office | 17 | 12 | $63.52 | $1,080 |
By year: 2022 $7,501 for 173 services; 2023 $8,061 for 177 services; 2024 $5,939 for 215 services.
Medicare prescription drug claims, 2024
In 2024, the drug Aasha Harish prescribed most often to Medicare patients was Azelastine Hcl, with 153 prescriptions and refills. In total Aasha Harish wrote 921 Medicare prescriptions that cost $1.3M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Azelastine Hcl Generic | 153 | 204 | 41 | $4,224 |
| Fluticasone Propionate Generic | 110 | 170 | 35 | $2,154 |
| Montelukast Sodium Generic | 78 | 153 | 21 | $915 |
| Dupixent Pen Dupilumab | 51 | 51 | Under 11 | $255K |
| Albuterol Sulfate Hfa Albuterol Sulfate | 47 | 50 | 17 | $1,470 |
| Ipratropium Bromide Generic | 41 | 53 | 15 | $1,237 |
| Dupixent Syringe Dupilumab | 31 | 31 | Under 11 | $116K |
| Fluticasone-Salmeterol Fluticasone Propion/Salmeterol | 29 | 41 | Under 11 | $6,139 |
| Famotidine Generic | 27 | 37 | Under 11 | $409 |
| Breztri Aerosphere Budesonide/Glycopyr/Formoterol | 25 | 25 | Under 11 | $15K |
| Epinephrine Generic | 22 | 22 | 15 | $7,663 |
| Fasenra Pen Benralizumab | 21 | 38 | Under 11 | $135K |
| Prednisone Generic | 16 | 18 | Under 11 | $145 |
| Xolair Omalizumab | 15 | 17 | Under 11 | $48K |
| Breo Ellipta Fluticasone/Vilanterol | 15 | 25 | Under 11 | $9,678 |
Brand drugs: 292 claims; generic drugs: 629 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Aasha Harish $935 ($935 in general payments such as food, travel and fees) from 6 companies. The largest payer was AstraZeneca Pharmaceuticals LP with $377.
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.